Search by Drug Name or NDC

    NDC 30142-0023-26 Childrens Multi Symptom Fever and Cold 160; 1; 5; 2.5 mg/5mL; mg/5mL; mg/5mL; mg/5mL Details

    Childrens Multi Symptom Fever and Cold 160; 1; 5; 2.5 mg/5mL; mg/5mL; mg/5mL; mg/5mL

    Childrens Multi Symptom Fever and Cold is a ORAL SUSPENSION in the HUMAN OTC DRUG category. It is labeled and distributed by Kroger Company. The primary component is ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 30142-0023
    Product ID 30142-023_adfdd49c-de8f-453e-93aa-6d61fde82e2d
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Childrens Multi Symptom Fever and Cold
    Proprietary Name Suffix n/a
    Non-Proprietary Name Acetaminophen, Chlorpheniramine Maleate, Dextromethorphan HBr, Phenylephrine HCl
    Product Type HUMAN OTC DRUG
    Dosage Form SUSPENSION
    Route ORAL
    Active Ingredient Strength 160; 1; 5; 2.5
    Active Ingredient Units mg/5mL; mg/5mL; mg/5mL; mg/5mL
    Substance Name ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name Kroger Company
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Rece
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 30142-0023-26 (30142002326)

    NDC Package Code 30142-023-26
    Billing NDC 30142002326
    Package 1 BOTTLE in 1 CARTON (30142-023-26) / 118 mL in 1 BOTTLE
    Marketing Start Date 2015-06-23
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 5f30c9e0-d172-4bb7-8223-0f98495bf140 Details

    Revised: 5/2020